Report Detail

Medical Industry Global and Japan PCR-based Enteric Disease Testing Market 2020 by Company, Type and Application, Forecast to 2025

  • RnM4019638
  • |
  • 11 June, 2020
  • |
  • Global
  • |
  • 150 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Industry

Market Overview
The PCR-based Enteric Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global PCR-based Enteric Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
PCR-based Enteric Disease Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, PCR-based Enteric Disease Testing market has been segmented into Analyzers/Instruments, Kits/Panels, etc.

Breakdown by Application, PCR-based Enteric Disease Testing has been segmented into Clostridium Difficile, Campylobacteriosis, Cholera, E. coli Infection, H. pylori Infection, Salmonellosis, Shigellosis, Rotavirus Infection, Norovirus Infection, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PCR-based Enteric Disease Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level PCR-based Enteric Disease Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PCR-based Enteric Disease Testing market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and PCR-based Enteric Disease Testing Market Share Analysis
PCR-based Enteric Disease Testing competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, PCR-based Enteric Disease Testing revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the PCR-based Enteric Disease Testing revenue and market share for each player covered in this report.

The major players covered in PCR-based Enteric Disease Testing are: Thermo Fisher Scientific, Trinity Biotech, Meridian Life Science, Vela Diagnostics, bioMerieux SA, CorisBioconcept, Etta Healthcare (Ovagene Oncology), Abbott (ALERE), Bio-Rad Laboratories, DiaSorin Molecular, Fluxergy, Genalyte, ExcitePCR (PositiveID Corporation), GenSpeed Biotech, Focus Diagnostics (DiaSorin Molecular), FluimediX, Flow Alliance, GeneFluidics, Future Horizon Scientific, Fluid-Screen, iLine Microsystems, Gulf Bio Analytical, IDEX Health&Science, Danaher, HemoCue, Hahn-Schickard, Inflammatix, Helvoet, etc. Among other players domestic and global, PCR-based Enteric Disease Testing market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers
Thermo Fisher Scientific
Trinity Biotech
Meridian Life Science
Vela Diagnostics
bioMerieux SA
CorisBioconcept
Etta Healthcare (Ovagene Oncology)
Abbott (ALERE)
Bio-Rad Laboratories
DiaSorin Molecular
Fluxergy
Genalyte
ExcitePCR (PositiveID Corporation)
GenSpeed Biotech
Focus Diagnostics (DiaSorin Molecular)
FluimediX
Flow Alliance
GeneFluidics
Future Horizon Scientific
Fluid-Screen
iLine Microsystems
Gulf Bio Analytical
IDEX Health&Science
Danaher
HemoCue
Hahn-Schickard
Inflammatix
Helvoet

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:
Analyzers/Instruments
Kits/Panels

Market segment by Application, can be divided into
Clostridium Difficile
Campylobacteriosis
Cholera
E. coli Infection
H. pylori Infection
Salmonellosis
Shigellosis
Rotavirus Infection
Norovirus Infection
Parasitic Enteric Disease


1 Market Overview

  • 1.1 Product Overview and Scope of PCR-based Enteric Disease Testing
  • 1.2 Classification of PCR-based Enteric Disease Testing by Type
    • 1.2.1 Overview: Global PCR-based Enteric Disease Testing Revenue by Type: 2015 Versus 2019 Versus 2025
    • 1.2.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Type in 2019
    • 1.2.3 Analyzers/Instruments
    • 1.2.4 Kits/Panels
  • 1.3 Global PCR-based Enteric Disease Testing Market by Application
    • 1.3.1 Overview: Global PCR-based Enteric Disease Testing Revenue by Application: 2015 Versus 2019 Versus 2025
    • 1.3.2 Clostridium Difficile
    • 1.3.3 Campylobacteriosis
    • 1.3.4 Cholera
    • 1.3.5 E. coli Infection
    • 1.3.6 H. pylori Infection
    • 1.3.7 Salmonellosis
    • 1.3.8 Shigellosis
    • 1.3.9 Rotavirus Infection
    • 1.3.10 Norovirus Infection
    • 1.3.11 Parasitic Enteric Disease
  • 1.4 Global PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 1.5 Global PCR-based Enteric Disease Testing Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.6 Global PCR-based Enteric Disease Testing Market Size by Regions (2015-2020)
  • 1.7 Global PCR-based Enteric Disease Testing Market Size and Forecast by Regions (2020-2025)
    • 1.7.1 North America PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
    • 1.7.2 Europe PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
    • 1.7.3 Asia PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
    • 1.7.4 South America PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
    • 1.7.5 Middle East & Africa PCR-based Enteric Disease Testing Status and Prospect (2015-2025)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific SWOT Analysis
    • 2.1.4 Thermo Fisher Scientific Product and Services
    • 2.1.5 Thermo Fisher Scientific PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.2 Trinity Biotech
    • 2.2.1 Trinity Biotech Details
    • 2.2.2 Trinity Biotech Major Business
    • 2.2.3 Trinity Biotech SWOT Analysis
    • 2.2.4 Trinity Biotech Product and Services
    • 2.2.5 Trinity Biotech PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.3 Meridian Life Science
    • 2.3.1 Meridian Life Science Details
    • 2.3.2 Meridian Life Science Major Business
    • 2.3.3 Meridian Life Science SWOT Analysis
    • 2.3.4 Meridian Life Science Product and Services
    • 2.3.5 Meridian Life Science PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.4 Vela Diagnostics
    • 2.4.1 Vela Diagnostics Details
    • 2.4.2 Vela Diagnostics Major Business
    • 2.4.3 Vela Diagnostics SWOT Analysis
    • 2.4.4 Vela Diagnostics Product and Services
    • 2.4.5 Vela Diagnostics PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.5 bioMerieux SA
    • 2.5.1 bioMerieux SA Details
    • 2.5.2 bioMerieux SA Major Business
    • 2.5.3 bioMerieux SA SWOT Analysis
    • 2.5.4 bioMerieux SA Product and Services
    • 2.5.5 bioMerieux SA PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.6 CorisBioconcept
    • 2.6.1 CorisBioconcept Details
    • 2.6.2 CorisBioconcept Major Business
    • 2.6.3 CorisBioconcept Product and Services
    • 2.6.4 CorisBioconcept PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.7 Etta Healthcare (Ovagene Oncology)
    • 2.7.1 Etta Healthcare (Ovagene Oncology) Details
    • 2.7.2 Etta Healthcare (Ovagene Oncology) Major Business
    • 2.7.3 Etta Healthcare (Ovagene Oncology) Product and Services
    • 2.7.4 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.8 Abbott (ALERE)
    • 2.8.1 Abbott (ALERE) Details
    • 2.8.2 Abbott (ALERE) Major Business
    • 2.8.3 Abbott (ALERE) Product and Services
    • 2.8.4 Abbott (ALERE) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.9 Bio-Rad Laboratories
    • 2.9.1 Bio-Rad Laboratories Details
    • 2.9.2 Bio-Rad Laboratories Major Business
    • 2.9.3 Bio-Rad Laboratories Product and Services
    • 2.9.4 Bio-Rad Laboratories PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.10 DiaSorin Molecular
    • 2.10.1 DiaSorin Molecular Details
    • 2.10.2 DiaSorin Molecular Major Business
    • 2.10.3 DiaSorin Molecular Product and Services
    • 2.10.4 DiaSorin Molecular PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.11 Fluxergy
    • 2.11.1 Fluxergy Details
    • 2.11.2 Fluxergy Major Business
    • 2.11.3 Fluxergy Product and Services
    • 2.11.4 Fluxergy PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.12 Genalyte
    • 2.12.1 Genalyte Details
    • 2.12.2 Genalyte Major Business
    • 2.12.3 Genalyte Product and Services
    • 2.12.4 Genalyte PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.13 ExcitePCR (PositiveID Corporation)
    • 2.13.1 ExcitePCR (PositiveID Corporation) Details
    • 2.13.2 ExcitePCR (PositiveID Corporation) Major Business
    • 2.13.3 ExcitePCR (PositiveID Corporation) Product and Services
    • 2.13.4 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.14 GenSpeed Biotech
    • 2.14.1 GenSpeed Biotech Details
    • 2.14.2 GenSpeed Biotech Major Business
    • 2.14.3 GenSpeed Biotech Product and Services
    • 2.14.4 GenSpeed Biotech PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.15 Focus Diagnostics (DiaSorin Molecular)
    • 2.15.1 Focus Diagnostics (DiaSorin Molecular) Details
    • 2.15.2 Focus Diagnostics (DiaSorin Molecular) Major Business
    • 2.15.3 Focus Diagnostics (DiaSorin Molecular) Product and Services
    • 2.15.4 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.16 FluimediX
    • 2.16.1 FluimediX Details
    • 2.16.2 FluimediX Major Business
    • 2.16.3 FluimediX Product and Services
    • 2.16.4 FluimediX PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.17 Flow Alliance
    • 2.17.1 Flow Alliance Details
    • 2.17.2 Flow Alliance Major Business
    • 2.17.3 Flow Alliance Product and Services
    • 2.17.4 Flow Alliance PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.18 GeneFluidics
    • 2.18.1 GeneFluidics Details
    • 2.18.2 GeneFluidics Major Business
    • 2.18.3 GeneFluidics Product and Services
    • 2.18.3 GeneFluidics PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.19 Future Horizon Scientific
    • 2.19.1 Future Horizon Scientific Details
    • 2.19.2 Future Horizon Scientific Major Business
    • 2.19.3 Future Horizon Scientific Product and Services
    • 2.19.4 Future Horizon Scientific PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.20 Fluid-Screen
    • 2.20.1 Fluid-Screen Details
    • 2.20.2 Fluid-Screen Major Business
    • 2.20.3 Fluid-Screen Product and Services
    • 2.20.4 Fluid-Screen PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.21 iLine Microsystems
    • 2.21.1 iLine Microsystems Details
    • 2.21.2 iLine Microsystems Major Business
    • 2.21.3 iLine Microsystems Product and Services
    • 2.21.4 iLine Microsystems PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.22 Gulf Bio Analytical
    • 2.22.1 Gulf Bio Analytical Details
    • 2.22.2 Gulf Bio Analytical Major Business
    • 2.22.3 Gulf Bio Analytical Product and Services
    • 2.22.4 Gulf Bio Analytical PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.23 IDEX Health&Science
    • 2.23.1 IDEX Health&Science Details
    • 2.23.2 IDEX Health&Science Major Business
    • 2.23.3 IDEX Health&Science Product and Services
    • 2.23.4 IDEX Health&Science PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.24 Danaher
    • 2.24.1 Danaher Details
    • 2.24.2 Danaher Major Business
    • 2.24.3 Danaher Product and Services
    • 2.24.4 Danaher PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.25 HemoCue
    • 2.25.1 HemoCue Details
    • 2.25.2 HemoCue Major Business
    • 2.25.3 HemoCue Product and Services
    • 2.25.4 HemoCue PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.26 Hahn-Schickard
    • 2.26.1 Hahn-Schickard Details
    • 2.26.2 Hahn-Schickard Major Business
    • 2.26.3 Hahn-Schickard Product and Services
    • 2.26.4 Hahn-Schickard PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.27 Inflammatix
    • 2.27.1 Inflammatix Details
    • 2.27.2 Inflammatix Major Business
    • 2.27.3 Inflammatix Product and Services
    • 2.27.4 Inflammatix PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
  • 2.28 Helvoet
    • 2.28.1 Helvoet Details
    • 2.28.2 Helvoet Major Business
    • 2.28.3 Helvoet Product and Services
    • 2.28.4 Helvoet PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

  • 3.1 Global PCR-based Enteric Disease Testing Market Size by Players (2015-2020)
  • 3.2 Japan PCR-based Enteric Disease Testing Market Size by Players (2015-2020)
  • 3.3 Market Concentration Rate
    • 3.3.1 Top 5 PCR-based Enteric Disease Testing Players Market Share
    • 3.3.2 Top 10 PCR-based Enteric Disease Testing Players Market Share

4 North America Market Size and Forecast by Countries

  • 4.1 North America PCR-based Enteric Disease Testing Market Size by Countries (2015-2020)
  • 4.2 North America PCR-based Enteric Disease Testing Market Size and Forecast by Countries (2015-2026)
  • 4.3 United States PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 4.4 Canada PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 4.5 Mexico PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

  • 5.1 Europe PCR-based Enteric Disease Testing Market Size by Countries (2015-2020)
  • 5.2 Europe PCR-based Enteric Disease Testing Market Size and Forecast by Countries (2015-2026)
  • 5.3 Germany PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 5.4 France PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 5.5 UK PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 5.6 Russia PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 5.7 Italy PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

  • 6.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Regions (2015-2020)
  • 6.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size and Forecast by Regions (2015-2026)
  • 6.3 China PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 6.4 Japan PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 6.5 Korea PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 6.6 India PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 6.7 Southeast Asia PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

  • 7.1 South America PCR-based Enteric Disease Testing Market Size by Countries (2015-2020)
  • 7.2 South America PCR-based Enteric Disease Testing Market Size and Forecast by Countries (2015-2026)
  • 7.3 Brazil PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 7.4 Argentina PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

  • 8.1 Middle East & Africa PCR-based Enteric Disease Testing Revenue by Regions (2015-2020)
  • 8.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size and Forecast by Countries (2015-2026)
  • 8.3 Saudi Arabia PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 8.4 UAE PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 8.5 Egypt PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)
  • 8.6 South Africa PCR-based Enteric Disease Testing Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

  • 9.1 Global PCR-based Enteric Disease Testing Market Size and Forecast by Type (2015-2025)
    • 9.1.1 Global PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
    • 9.1.2 Global PCR-based Enteric Disease Testing Market Size Forecast by Type (2020-2025)
  • 9.2 Japan PCR-based Enteric Disease Testing Market Size and Forecast by Type (2015-2025)
    • 9.2.1 Japan PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
    • 9.2.2 Japan PCR-based Enteric Disease Testing Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

  • 10.1 Global PCR-based Enteric Disease Testing Market Size and Forecast by Application (2015-2025)
    • 10.1.1 Global PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
    • 10.1.2 Global PCR-based Enteric Disease Testing Market Size Forecast by Application (2020-2025)
  • 10.2 Japan PCR-based Enteric Disease Testing Market Size and Forecast by Application (2015-2025)
    • 10.2.1 Japan PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
    • 10.2.2 Japan PCR-based Enteric Disease Testing Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

    12 Appendix

    • 12.1 Methodology
    • 12.2 Data Source
    • 12.3 Disclaimer

    Summary:
    Get latest Market Research Reports on PCR-based Enteric Disease Testing. Industry analysis & Market Report on PCR-based Enteric Disease Testing is a syndicated market report, published as Global and Japan PCR-based Enteric Disease Testing Market 2020 by Company, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of PCR-based Enteric Disease Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,705.50
    5,411.00
    3,258.50
    6,517.00
    534,415.00
    1,068,830.00
    295,400.00
    590,800.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report